News

Starting in 2025, the Eylea franchise as a whole began to decline due to competitive pressure from long-acting Vabysmo, which competes with Eylea HD, and Pabvlu, a biosimilar version of the original ...
Libtayo was the sixth PD-L/PD-L1 inhibitor to reach the market, starting out as a therapy for another skin cancer called cutaneous squamous cell carcinoma (CSCC), and the rarity of that disease ...
Key topics include results from the Phase 3 trial of Libtayo for high-risk cutaneous squamous cell carcinoma and data on linvoseltamab for relapsed or refractory multiple myeloma. Other research ...
MADISON – Democratic Gov. Tony Evers and Republican legislative leaders are holding discussions about a tax package — a potential collaboration that has been rare throughout the last six years ...
A Bronx store has gone viral for peddling $4-a-pop “mystery” packages from retailers such as Amazon and Walmart that were returned and are now up for resale — but the set-up isn’t without ...
BRUSSELS, May 6 (Reuters) - The European Commission proposed adding more individuals and over 100 vessels linked to Russia's shadow fleet to its 17th package of sanctions against Moscow ...
A VIEWER NAMED CATHERINE SENT ME THIS EMAIL. WE RECEIVED A PACKAGE ADDRESSED TO A PERSON THAT WAS NOT US, BUT IT WAS OUR ADDRESS. IT WAS ONE CAN OF CREAM OF MUSHROOM SOUP. WHAT IS THE SCAM WITH ...
Omaha police are investigating after a suspicious package was found at the post office. The incident happened at the U.S. Postal Service near 11th and Pacific streets. Police said there was a ...
"We are prepared and equipped to carry out enhanced package screening and enforce orders effectively as outlined" in Trump's executive order ending de minimis treatment for China, the spokesperson ...
It was only a package theft from the front porch of a North Texas home, but the homeowners couldn't believe their eyes when they saw on their doorbell security camera who was allegedly involved in ...
Clinical Trial Supply Agreement Announced with Regeneron for Libtayo (cemiplimab): In February, Immuneering announced a clinical trial supply agreement with Regeneron Pharmaceuticals for its anti ...